OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Practical pearls to improve the efficacy and tolerability of levodopa in Parkinson’s disease
Abhishek Lenka, Gianluca Di Maria, Guillaume Lamotte, et al.
Expert Review of Neurotherapeutics (2022) Vol. 22, Iss. 6, pp. 489-498
Closed Access | Times Cited: 12

Showing 12 citing articles:

Treatment of Motor Symptoms of Parkinson’s Disease
Luca Marsili, Matteo Bologna, Lily Y. Chen, et al.
Neurologic Clinics (2025) Vol. 43, Iss. 2, pp. 341-363
Closed Access

Carbidopa: beyond Parkinson’s disease
Abhishek Lenka, Steven Vernino
Clinical Autonomic Research (2025)
Closed Access

Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders
Pratik Chakraborty, Chiranjib Bhattacharyya, Ranabir Sahu, et al.
Journal of Drug Delivery Science and Technology (2023) Vol. 91, pp. 105267-105267
Closed Access | Times Cited: 9

Does Delaying Levodopa Prevent Motor Complications in Parkinson's Disease? A Meta‐Analysis
Luís Guilherme Ramanzini, Julia Maria Frare, Luís Fernando Muniz Camargo, et al.
Movement Disorders Clinical Practice (2024) Vol. 11, Iss. 10, pp. 1195-1202
Open Access | Times Cited: 3

The mechanistic view of non-coding RNAs as a regulator of inflammatory pathogenesis of Parkinson’s disease
Yuan Li, Chunlei Yu, Xiaobing Jiang, et al.
Pathology - Research and Practice (2024) Vol. 258, pp. 155349-155349
Closed Access | Times Cited: 2

Advantages and Disadvantages of Current Therapeutics and Phytochemicals for Age-Related Brain Disorders
Ahamed Basha Abdul Bari, Madhan Krishnan, Shyamaladevi Babu
(2024), pp. 355-372
Closed Access

Nanomaterials as Drug Delivery Vehicles for Therapy of Parkinson's Disease
Aleena James Chirayimmel, Gursharan Kaur, Palak Rana, et al.
(2024), pp. 303-343
Closed Access

Novel drug delivery system in the management of Parkinson’s disease
Atul Kabra, Ritika Puri, Pradeep Goyal, et al.
Elsevier eBooks (2024), pp. 185-198
Closed Access

Influence of intra-abomasal administration of L-DOPA on circulating catecholamines and feed intake in cattle
Ériton Egídio Lisboa Valente, J. L. Klotz, Amanda M. Egert-McLean, et al.
Frontiers in Animal Science (2023) Vol. 4
Open Access | Times Cited: 1

Medial Forebrain Bundle Axotomy Induced Dopaminergic Neuronal Degeneration is Accompanied with Microglial Activation
Gyu-Ri Kim, Dae‐Yong Song, Yoon‐Jung Choy
Indian Journal of Animal Research (2023), Iss. Of
Open Access | Times Cited: 1

Molecular Docking of Zingerone and Gamma-Mangostin to Inhibit MAO-B and Catechol-O-Methyltransferase (COMT) in the Treatment of Parkinson’s Disease
A. Saraiva, João Paulo Oliveira da Silva, Jose Sousa, et al.
Research Society and Development (2022) Vol. 11, Iss. 16, pp. e189111637853-e189111637853
Open Access | Times Cited: 1

Deep brain stimulation and the treatment of movement disorders
Joseph Candelario‐Mckeown
British Journal of Neuroscience Nursing (2022) Vol. 18, Iss. 6, pp. 258-263
Closed Access

Page 1

Scroll to top